Suzanne Trudel

7PUBLICATIONS
43CO-AUTHORS
Tumour immunologyHaematological tumoursGene and molecular therapyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 16, 2026
Identification of broadly tumour-reactive γδ TCRs from multiple myeloma.

|Jul 22, 2026
FcRH5×CD3 bispecific antibody cevostamab in relapsed or refractory multiple myeloma: a phase 1 trial.

|Mar 11, 2026
Debulking Chemotherapy Can Overcome Primary Resistance to Teclistamab in Relapsed/Refractory Multiple Myeloma.

Rintu Sharma, Andree-Anne Pelland, Katherine Lajkosz

|Jan 04, 2024
Belantamab mafodotin, pomalidomide and dexamethasone in refractory multiple myeloma: a phase 1/2 trial.

Suzanne Trudel, Arleigh McCurdy, Martha L Louzada

|Oct 02, 2023
Elranatamab in relapsed or refractory multiple myeloma: the MagnetisMM-1 phase 1 trial.

Nizar J Bahlis, Caitlin L Costello, Noopur S Raje

|Jan 13, 2023
Single-cell profiling of multiple myeloma reveals molecular response to FGFR3 inhibitor despite clinical progression.

Danielle C Croucher, Anup Joseph Devasia, Dor D Abelman

Pageof 2

Frequent Collaborators

2 joint publications

Danielle C Croucher

2 joint publications

Trevor J Pugh

2 joint publications

Engin Gul

2 joint publications

Alexander M Lesokhin